IRIS

Sfoglia per Rivista  HEPATOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 47 a 66 di 123
Titolo Data di pubblicazione Autore(i) File
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta???analysis 1-gen-2022 Ian, Lockart; Yeo, Malcolm G. H.; Behzad, Hajarizadeh; Dore, Gregory J.; Mark, Danta; Kazumichi, Abe; Fabrice, Carrat; Clovis Lusivika Nzinga, ; Elisabetta, Degasperi; Vito Di Marco, ; Jinlin, Hou; Jessica, Howell; Naveed, Z Janjua; Stanley, Wong; Takashi, Kumada; LLEO DE NALDA, Ana; Marcello, Persico; Anna, S Lok; Lai, Wei; Ming, Yang; Ekaterina, Nabatchikova; Mindie, H Nguyen; Juan Antonio Pineda, ; Mar??a, Reig; Gamal, Shiha; Ming Lung Yu, ; Pei Chien Tsai,
Hepatic mitochondrial beta-oxidation in patients with Nonalcoholic-Steatohepatitis (NASH) assessed by 13C-octanoate breath test 1-gen-2002 Miele, L; Grieco, A; Armuzzi, A; Candelli, M; Zocco, Ma; Forgione, A; Rapaccini, Gl; Gasbarrini, G; Gasbarrini, A
Hepatic mitochondrial function assessment through C-13-methionine and C-13-sodium octanoate breath tests 1-gen-1999 Armuzzi, A; Gasbarrini, A; Zocco, Ma; Cremonini, F; Marcoccia, S; Di Campli, C; Pola, R; Pola, P; Grieco, A; Anti, M; Gasbarrini, G
Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct antiviral agents 1-gen-2016 Ceccherini Silberstein, Francesca; Di Maio, Velia Chiara; Aragri, Marianna; Ciotti, Marco; Cento, Valeria; Perno, Carlo Federico
High efficacy of hepatitis C re-treatment strategies after protease inhibitors failure in real-life settings 1-gen-2016 Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Masetti, C; Magni, Cf; Micheli, V; Billotti, E; Di Paolo, D; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, La; Marenco, S; Danieli, E; Di Maio, Vc; Aragri, M; Milana, M; Francioso, S; Bertoli, A; Antonucci, F; Esvan, R; Sarmati, L; Sarrecchia, C; Coppola, N; Messina, V; Claar, E; Puoti, M; Ciancio, A; Bonora, S; Babudieri, S; Di Biagio, A; Picciotto, A; Pasquazzi, C; Andreoni, M; Mura, Ms; Taliani, G; Rizzardini, G; Angelico, M; Ceccherini-Silberstein, F; Perno, Cf
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls 1-gen-2008 Invernizzi, P.; Selmi, C.; Poli, F.; Frison, S.; Floreani, A.; Alvaro, D.; Almasio, P.; Rosina, F.; Marzioni, M.; Fabris, L.; Muratori, L.; Qi, L.; Seldin, M. F.; Gershwin, M. E.; Podda, M.; Andreoletti, M.; Andriulli, A.; Baldini, V.; Battezzati, P. M.; Benedetti, A.; Bernuzzi, F.; Bianchi, F. B.; Bianchi, I.; Bignotto, M.; Bragazzi, M. C.; Brunetto, M.; Caimi, M.; Caliari, L.; Caporaso, N.; Casella, G.; Casiraghi, A.; Colli, A.; Colombo, M.; Conte, D.; Croce, L.; Crosignani, A.; Dottorini, L.; Ferrari, C.; Fraquelli, M.; Frati, C. E.; Galli, A.; Lleo, A.; Mancino, M. G.; Mandelli, G.; Marra, F.; Montanari, R.; Monti, V.; Morini, L.; Morisco, F.; Niro, G.; Palasciano, G.; Calmieri, V. O.; Pasini, S.; Picciotto, A.; Portincasa, P.; Pozzoli, V.; Spinzi, G.; Strazzabosco, M.; Tiribelli, C.; Toniutto, P.; Zerminai, P.; Zuin, M.
IMMUNE CHANGES DURING THE EARLY STEPS OF HUMAN LIVER CARCINOGENESIS 1-gen-2019 Meylan, M; Petitprez, F; Lacroix, L; Di Tommaso, L; Roncalli, M; Pawlotsky, Jm; Fridman, C; Fridman, Wh; Calderaro, J
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis 1-gen-2012 Lleo, A; Liao, J; Invernizzi, P; Zhao, M; Bernuzzi, F; L, Ma; Lanzi, G; Ansari, Aa; Coppel, Rl; Zhang, P; Y, Li; Zhou, Z; Lu Q and Gershwin, Me.
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection 1-gen-2012 Varchetta, S.; Mele, D.; Mantovani, S.; Oliviero, B.; Cremonesi, E.; Ludovisi, S.; Michelone, G.; Alessiani, M.; Rosati, R.; Montorsi, M.; Mondelli, M. U.
Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. 1-gen-2011 Mueller, Km; Kornfeld, Jw; Friedbichler, K; Blaas, L; Egger, G; Esterbauer, H; Hasselblatt, P; Schlederer, M; Haindl, S; Wagner, Ku; Engblom, D; Haemmerle, G; Kratky, D; Sexl, V; Kenner, L; Kozlov, Av; Terracciano, L; Zechner, R; Schuetz, G; Casanova, E; Pospisilik, Ja; Heim, Mh; Moriggl, R
Increased risk of hepatocellular carcinoma in HCV (+) non responder cirrhotics with high liver cell proliferation 1-gen-2008 Donato, M. F.; Arosio, E.; Aghemo, A.; Rumi, M. G.; Ronchi, G.; Colombo, M.
Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice 1-gen-2005 Croquelois, A; Blindenbacher, A; Terracciano, L; Wang, X; Langer, I; Radtke, F; Heim, Mh.
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 1-gen-2012 De Nicola, S; Aghemo, A; Rumi, Mg; Galmozzi, E; Valenti, L; Soffredini, R; De Francesco, R; Prati, Gm; D'Ambrosio, R; Cheroni, C; Donato, Mf; Colombo, M
Interleukin 6 is important for survival after partial hepatectomy in mice 1-gen-2003 Blindenbacher, A; Wang, X; Langer, I; Savino, R; Terracciano, L; Heim, Mh
Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice? 1-gen-2013 Galmozzi, E; De Nicola, S; Aghemo, A; Colombo, M
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1 1-gen-2019 Zeuzem, S; Bourgeois, S; Greenbloom, S; Buti, M; Aghemo, A; Lampertico, P; Janczewska, E; Lim, Sg; Moreno, C; Buggisch, P; Tam, E; Corbett, C; Willems, W; Vijgen, L; Fevery, B; Ouwerkerk-Mahadevan, S; Ackaert, O; Beumont, M; Kalmeijer, R; Sinha, R; Biermer, M
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity 1-gen-2009 Zhong, B.; Strnad, P.; Selmi, C.; Invernizzi, P.; Tao, G. Z.; Caleffi, A.; Chen, M.; Bianchi, I.; Podda, M.; Pietrangelo, A.; Gershwin, M. E.; Omary, M. B.
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study 1-gen-2009 Aghemo, A.; Rumi, M.; Prati, G. M.; D’Ambrosio, R.; De Nicola, S.; Colombo, M.
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry 1-gen-2023 Slooter, Charlotte D; van den Brand, Floris F; Lleo, Ana; Colapietro, Francesca; Lenzi, Marco; Muratori, Paolo; Kerkar, Nanda; Dalekos, George N; Zachou, Kalliopi; Lucena, M Isabel; Robles-Díaz, Mercedes; Di Zeo-Sánchez, Daniel E; Andrade, Raúl J; Montano-Loza, Aldo J; Lytvyak, Ellina; Lissenberg-Witte, Birgit I; Maisonneuve, Patrick; Bouma, Gerd; Macedo, Guilherme; Liberal, Rodrigo; de Boer, Ynto S
Large liver cell change in hepatitis B virus-related liver cirrhosis 1-gen-2009 Kim, H.; Oh, B. K.; Roncalli, M.; Park, C.; Yoon, S. M.; Yoo, J. E.; Park, Y. N.
Mostrati risultati da 47 a 66 di 123
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile